MAPT and Alzheimer disease: Determining the level of the microtubule-associated protein, tau, the main constituent of NFT, and the prevalence and subcellular localisation of its different phosphorylated forms would therefore seem essential, since tau appears to act as a key mediator or enabler of both Aβ- and apoE4-dependent AD pathogenesis.